Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
8.59
+0.01 (0.12%)
At close: Jan 5, 2026, 4:00 PM EST
8.51
-0.08 (-0.93%)
After-hours: Jan 5, 2026, 7:53 PM EST
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $2.94 billion as of January 5, 2026. Its market cap has increased by 211.39% in one year.
Market Cap
2.94B
Enterprise Value
2.45B
1-Year Change
211.39%
Ranking
Category
Stock Price
$8.59
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $2.94B, an increase of 1,587.85%. That is a compound annual growth rate of 69.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 2.94B | -4.13% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |